Sophosbuvir

Sofosbuvir  ( English Sofosbuvir , lat. Sofosbuvirum ) is a synthetic antiviral from a group of nucleoside analogues for oral administration. Sophoswvir is developed by the American company «Pharmasset» under the name «Sovaldy», and from 2012, after the purchase of shares «Pharmasset» by «Gilead

Читать далее